Skip to main content
Top
Published in: BMC Infectious Diseases 1/2004

Open Access 01-12-2004 | Research article

A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma

Authors: Dirk Theegarten, Olaf Anhenn, Helmut Hotzel, Mathias Wagner, Alessandro Marra, Georgios Stamatis, Grigori Mogilevski, Konrad Sachse

Published in: BMC Infectious Diseases | Issue 1/2004

Login to get access

Abstract

Background

Chlamydiales are familiar causes of acute and chronic infections in humans and animals. Human pulmonary emphysema is a component of chronic obstructive pulmonary disease (COPD) and a condition in which chronic inflammation manifested as bronchiolitis and intra-alveolar accumulation of macrophages is common. It is generally presumed to be of infectious origin. Previous investigations based on serology and immunohistochemistry indicated Chlamydophila pneumoniae infection in cases of COPD. Furthermore, immunofluorescence with genus-specific antibodies and electron microscopy suggested involvement of chlamydial infection in most cases of pulmonary emphysema, but these findings could not be verified by PCR. Therefore, we examined the possibility of other chlamydial species being present in these patients.

Methods

Tissue samples from patients having undergone lung volume reduction surgery for advanced alpha-1 antitrypsin deficiency (AATD, n = 6) or non-alpha-1 antitrypsin deficiency emphysema (n = 34) or wedge resection for hamartochondroma (n = 14) were examined by transmission electron microscopy and PCR.

Results

In all cases of AATD and 79.4% of non-AATD, persistent chlamydial infection was detected by ultrastructural examination. Intra-alveolar accumulation of macrophages and acute as well as chronic bronchiolitis were seen in all positive cases. The presence of Chlamydia psittaci was demonstrated by PCR in lung tissue of 66.7% AATD vs. 29.0% non-AATD emphysema patients. Partial DNA sequencing of four positive samples confirmed the identity of the agent as Chlamydophila psittaci. In contrast, Chlamydophila pneumoniae was detected only in one AATD patient. Lung tissue of the control group of non-smokers with hamartochondroma was completely negative for chlamydial bodies by TEM or chlamydial DNA by PCR.

Conclusions

These data indicate a role of Chlamydophila psittaci in pulmonary emphysema by linking this chronic inflammatory process to a chronic infectious condition. This raises interesting questions on pathogenesis and source of infection.
Appendix
Available only for authorised users
Literature
2.
go back to reference Schachter J: Infection and disease epidemiology. In Chlamydia. Intracellular biology, pathogenesis, and immunity. Edited by: Stephens RS. 1999, Washington: American Society for Microbiology Press, 139-169. Schachter J: Infection and disease epidemiology. In Chlamydia. Intracellular biology, pathogenesis, and immunity. Edited by: Stephens RS. 1999, Washington: American Society for Microbiology Press, 139-169.
3.
go back to reference Ritter J: Beitrag zur Frage des Pneumotyphus. Eine Hausepidemie in Uster (Schweiz) betreffend. Dtsch Arch Klin Med. 1879, 25: 53-96. Ritter J: Beitrag zur Frage des Pneumotyphus. Eine Hausepidemie in Uster (Schweiz) betreffend. Dtsch Arch Klin Med. 1879, 25: 53-96.
4.
go back to reference Everett KDE, Bush RM, Andersen AA: Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol. 1999, 49: 415-440.CrossRefPubMed Everett KDE, Bush RM, Andersen AA: Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol. 1999, 49: 415-440.CrossRefPubMed
5.
go back to reference Grayston JT, Kuo CC, Wang SP, Altman J: A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection. New Engl J Med. 1986, 315: 161-168.CrossRefPubMed Grayston JT, Kuo CC, Wang SP, Altman J: A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection. New Engl J Med. 1986, 315: 161-168.CrossRefPubMed
6.
go back to reference Grayston JT, Wang S-P: History of Chlamydia pneumoniae (TWAR). In Chlamydia pneumoniae. The Lung and the Heart. Edited by: Allegra L, Blasi F. 1999, Milan: Springer, 1-8.CrossRef Grayston JT, Wang S-P: History of Chlamydia pneumoniae (TWAR). In Chlamydia pneumoniae. The Lung and the Heart. Edited by: Allegra L, Blasi F. 1999, Milan: Springer, 1-8.CrossRef
7.
go back to reference Hertzen Lv, Alakärppä H, Koskinen R, Liippo K, Surcel H-M, Leinonen M, Saikku P: Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect. 1997, 118: 155-164. 10.1017/S095026889600725X.CrossRef Hertzen Lv, Alakärppä H, Koskinen R, Liippo K, Surcel H-M, Leinonen M, Saikku P: Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect. 1997, 118: 155-164. 10.1017/S095026889600725X.CrossRef
8.
go back to reference Hahn DL: Chlamydia pneumoniae, asthma, and COPD: what is the evidence?. Ann Allergy Asthma Immunol. 1999, 83: 339-344.CrossRef Hahn DL: Chlamydia pneumoniae, asthma, and COPD: what is the evidence?. Ann Allergy Asthma Immunol. 1999, 83: 339-344.CrossRef
9.
go back to reference Mogulkoc N, Karakurt S, Isalska B, Bayindir Ü, Celikel T, Korten V, Colpan N: Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med. 1999, 160: 349-353.CrossRefPubMed Mogulkoc N, Karakurt S, Isalska B, Bayindir Ü, Celikel T, Korten V, Colpan N: Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med. 1999, 160: 349-353.CrossRefPubMed
10.
go back to reference Beatty WL, Morrison RP, Byrne G: Persistent Chlamydiae. From cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 1994, 58: 686-699.PubMedPubMedCentral Beatty WL, Morrison RP, Byrne G: Persistent Chlamydiae. From cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 1994, 58: 686-699.PubMedPubMedCentral
11.
go back to reference Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J: Persistent infection with Chlamydia pneumonia following acute respiratory illness. Clin Infect Dis. 1992, 14: 178-182.CrossRefPubMed Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J: Persistent infection with Chlamydia pneumonia following acute respiratory illness. Clin Infect Dis. 1992, 14: 178-182.CrossRefPubMed
12.
go back to reference Wu L, Skinner SJM, Lambie N, Vuletic JC, Blasi F, Black PN: Immunohistochemical staining forChlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 162: 1148-1151.CrossRefPubMed Wu L, Skinner SJM, Lambie N, Vuletic JC, Blasi F, Black PN: Immunohistochemical staining forChlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 162: 1148-1151.CrossRefPubMed
13.
go back to reference Berger L, Volp K, Mathews S, Speare R, Timms P: Chlamydia pneumoniae in a free-ranging giant barred frog (Mixophyes iteratus) from Australia. J Clin Microbiol. 1999, 37: 2378-2380.PubMedPubMedCentral Berger L, Volp K, Mathews S, Speare R, Timms P: Chlamydia pneumoniae in a free-ranging giant barred frog (Mixophyes iteratus) from Australia. J Clin Microbiol. 1999, 37: 2378-2380.PubMedPubMedCentral
14.
go back to reference Hotzel H, Grossmann E, Mutschmann F, Sachse K: Genetic characterization of a Chlamydophila pneumoniae isolate from an african frog and comparison to currently accepted biovars. Syst Appl Microbiol. 2001, 24: 63-66.CrossRefPubMed Hotzel H, Grossmann E, Mutschmann F, Sachse K: Genetic characterization of a Chlamydophila pneumoniae isolate from an african frog and comparison to currently accepted biovars. Syst Appl Microbiol. 2001, 24: 63-66.CrossRefPubMed
15.
go back to reference Bodetti TJ, Jacobson E, Wan C, Hafner L, Pospischil A, Rose K, Timms P: Molecular evidence to support the expansion of the hostrange of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Syst Appl Microbiol. 2002, 25: 146-152.CrossRefPubMed Bodetti TJ, Jacobson E, Wan C, Hafner L, Pospischil A, Rose K, Timms P: Molecular evidence to support the expansion of the hostrange of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Syst Appl Microbiol. 2002, 25: 146-152.CrossRefPubMed
16.
go back to reference Theegarten D, Stamatis G, Morgenroth K: The role of persisting infections in the pathogenesis of pulmonary emphysema. Electron microscopy reveals a probable bacterial colonization of the alveolar space and the bronchioles. Pathol Res Pract. 1999, 195: 89-92.CrossRefPubMed Theegarten D, Stamatis G, Morgenroth K: The role of persisting infections in the pathogenesis of pulmonary emphysema. Electron microscopy reveals a probable bacterial colonization of the alveolar space and the bronchioles. Pathol Res Pract. 1999, 195: 89-92.CrossRefPubMed
17.
go back to reference Theegarten D, Mogilevski G, Anhenn O, Stamatis G, Jaeschock R, Morgenroth K: The role of Chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis. Virchows Arch. 2000, 437: 190-193. 10.1007/s004280000242.CrossRefPubMed Theegarten D, Mogilevski G, Anhenn O, Stamatis G, Jaeschock R, Morgenroth K: The role of Chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis. Virchows Arch. 2000, 437: 190-193. 10.1007/s004280000242.CrossRefPubMed
18.
go back to reference Theegarten D, Teschler H, Stamatis G, Konietzko N, Morgenroth K: Pathologisch-anatomische Befunde bei der chirurgischen Lungenvolumenreduktion des fortgeschrittenen Emphysems. Pneumologie. 1998, 52: 702-706.PubMed Theegarten D, Teschler H, Stamatis G, Konietzko N, Morgenroth K: Pathologisch-anatomische Befunde bei der chirurgischen Lungenvolumenreduktion des fortgeschrittenen Emphysems. Pneumologie. 1998, 52: 702-706.PubMed
19.
go back to reference Maass M, Bartels CB, Engel PM, Mamat U, Sievers H-H: Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998, 31: 827-831. 10.1016/S0735-1097(98)00016-3.CrossRefPubMed Maass M, Bartels CB, Engel PM, Mamat U, Sievers H-H: Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998, 31: 827-831. 10.1016/S0735-1097(98)00016-3.CrossRefPubMed
20.
go back to reference Theegarten D, Mogilevski G, Anhenn O, Stamatis G, Maass M, Morgenroth K: Evidence for chronic Chlamydia pneumoniae infection in pulmonary emphysema. Eur Respir J. 2000, 16 (Suppl 31): 333s- Theegarten D, Mogilevski G, Anhenn O, Stamatis G, Maass M, Morgenroth K: Evidence for chronic Chlamydia pneumoniae infection in pulmonary emphysema. Eur Respir J. 2000, 16 (Suppl 31): 333s-
21.
go back to reference Cassina PC, Teschler H, Konietzko N, Theegarten D, Stamatis G: Two-year results after lung volume reduction surgery in alpha-1-antitrypsin deficiency versus smoker's emphysema. Eur Respir J. 1998, 12: 1028-1032. 10.1183/09031936.98.12051028.CrossRefPubMed Cassina PC, Teschler H, Konietzko N, Theegarten D, Stamatis G: Two-year results after lung volume reduction surgery in alpha-1-antitrypsin deficiency versus smoker's emphysema. Eur Respir J. 1998, 12: 1028-1032. 10.1183/09031936.98.12051028.CrossRefPubMed
22.
go back to reference Kaltenböck B, Schmeer N, Schneider R: Evidence for numerous omp 1 alleles of porcine Chlamydia trachomatis and novel chlamydial species obtained by PCR. J Clin Microbiol. 1997, 35: 1835-1841.PubMedPubMedCentral Kaltenböck B, Schmeer N, Schneider R: Evidence for numerous omp 1 alleles of porcine Chlamydia trachomatis and novel chlamydial species obtained by PCR. J Clin Microbiol. 1997, 35: 1835-1841.PubMedPubMedCentral
23.
go back to reference Sachse K, Hotzel H: Detection and differentiation of chlamydiae by nested PCR. In PCR detection of microbial pathogens: Methods and protocols. Edited by: Sachse K, Frey J. 2002, Meth Mol Biol, 216: 231-246.CrossRef Sachse K, Hotzel H: Detection and differentiation of chlamydiae by nested PCR. In PCR detection of microbial pathogens: Methods and protocols. Edited by: Sachse K, Frey J. 2002, Meth Mol Biol, 216: 231-246.CrossRef
25.
go back to reference Salisch H, Malottki Kv, Ryll M, Hinz K-H: Chlamydial infections of poultry and human health. Worlds Poult Sci J. 1996, 52: 279-308.CrossRef Salisch H, Malottki Kv, Ryll M, Hinz K-H: Chlamydial infections of poultry and human health. Worlds Poult Sci J. 1996, 52: 279-308.CrossRef
26.
28.
go back to reference Shor A: A pathologist's view of organisms and human atherosclerosis. J Infect Dis. 2001, 183: 1428-1429. 10.1086/319873.CrossRefPubMed Shor A: A pathologist's view of organisms and human atherosclerosis. J Infect Dis. 2001, 183: 1428-1429. 10.1086/319873.CrossRefPubMed
29.
go back to reference Chi EY, Kuo CC, Grayston JT: Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol. 1987, 169: 3757-3763.PubMedPubMedCentral Chi EY, Kuo CC, Grayston JT: Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol. 1987, 169: 3757-3763.PubMedPubMedCentral
30.
go back to reference Vanrompay D, Charlier G, Ducatelle R, Haesebrouck F: Ultrastructural changes in avian Chlamydia psittaci serovar A-, B-, and D-infected Buffalo Green Monkey cells. Infect Immun. 1996, 64: 1265-1271.PubMedPubMedCentral Vanrompay D, Charlier G, Ducatelle R, Haesebrouck F: Ultrastructural changes in avian Chlamydia psittaci serovar A-, B-, and D-infected Buffalo Green Monkey cells. Infect Immun. 1996, 64: 1265-1271.PubMedPubMedCentral
31.
go back to reference Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, Freschi M, Villa E, Boiocchi M, Dolcetti R: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004, 96: 586-594. 10.1093/jnci/djh102.CrossRefPubMed Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, Freschi M, Villa E, Boiocchi M, Dolcetti R: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004, 96: 586-594. 10.1093/jnci/djh102.CrossRefPubMed
32.
go back to reference Barnes P: Chronic obstructive pulmonary disease. New Engl J Med. 2000, 343: 269-280. 10.1056/NEJM200007273430407.CrossRefPubMed Barnes P: Chronic obstructive pulmonary disease. New Engl J Med. 2000, 343: 269-280. 10.1056/NEJM200007273430407.CrossRefPubMed
33.
go back to reference Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 160: S29-32.CrossRefPubMed Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 160: S29-32.CrossRefPubMed
34.
go back to reference Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang Y-X, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF: Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in Chlamydial pathogenesis. J Clin Invest. 1997, 99: 77-87.CrossRefPubMedPubMedCentral Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang Y-X, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF: Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in Chlamydial pathogenesis. J Clin Invest. 1997, 99: 77-87.CrossRefPubMedPubMedCentral
35.
go back to reference Kol A, Sukhova GK, Lichtman AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation. 1998, 98: 300-307.CrossRefPubMed Kol A, Sukhova GK, Lichtman AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation. 1998, 98: 300-307.CrossRefPubMed
Metadata
Title
A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma
Authors
Dirk Theegarten
Olaf Anhenn
Helmut Hotzel
Mathias Wagner
Alessandro Marra
Georgios Stamatis
Grigori Mogilevski
Konrad Sachse
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2004
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-4-38

Other articles of this Issue 1/2004

BMC Infectious Diseases 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.